DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
67	多発性嚢胞腎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00283686 (ClinicalTrials.gov)	January 2006	26/1/2006	HALT Progression of Polycystic Kidney Disease Study A	HALT Progression of Polycystic Kidney Disease Study A	Kidney, Polycystic	Drug: Lisinopril;Drug: Telmisartan;Drug: Placebo;Other: Standard Blood Pressure Control;Other: Low Blood Pressure Control	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Boehringer Ingelheim;Merck Sharp & Dohme Corp.;Polycystic Kidney Disease Foundation;University of Pittsburgh;Washington University School of Medicine	Completed	15 Years	64 Years	All	558	Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

January 2006

26/1/2006

HALT Progression of Polycystic Kidney Disease Study A

Kidney, Polycystic

Drug: Lisinopril;Drug: Telmisartan;Drug: Placebo;Other: Standard Blood Pressure Control;Other: Low Blood Pressure Control

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Boehringer Ingelheim;Merck Sharp & Dohme Corp.;Polycystic Kidney Disease Foundation;University of Pittsburgh;Washington University School of Medicine

Completed

15 Years

64 Years

All

558

Phase 3

United States